Around the world, strategic investments in health not only deliver better health and improve well-being for more people, but also bolster economies, create jobs, and enhance local communities and their development. In other words, investing in health is a vital economic and societal catalyst. As the largest and most diversified health care company in the world, it is Our Credo obligation to "be good citizens -- support good works and charities and bear our fair share of taxes. We must encourage civic improvements and better health and education."
At Johnson & Johnson, we believe that advances in health care can be amplified and accelerated through collaborations with businesses, governments, multinational organizations, philanthropic organizations, patient associations and academia. By working together, our respective platforms and expertise can maximize the social and economic returns on our existing health investments.
Johnson & Johnson and its subsidiaries (the “Company”) have approximately 126,400 employees worldwide engaged in the research and development, manufacture and sale of a broad range of products in the health care field. Johnson & Johnson is a holding company, which has more than 230 operating companies conducting business in virtually all countries of the world. The Company’s primary focus is products related to human health and well-being. Johnson & Johnson was incorporated in the State of New Jersey in 1887.
The Executive Committee of Johnson & Johnson is the principal management group responsible for the strategic operations and allocation of the resources of the Company. This Committee oversees and coordinates the activities of the Company’s three business segments: Consumer, Pharmaceutical and Medical Devices. Within the strategic parameters provided by the Committee, senior management groups at U.S. and international operating companies are each responsible for their own strategic plans and the day-to-day operations of those companies. GRI 103-2 Each subsidiary within the business segments is, with limited exceptions, managed by residents of the country where located. GRI 202-2
Economic Value Generated and Distributed GRI 201-1
A basic indicator of our economic impact is calculated using economic value generated and economic value distributed, as outlined by the Global Reporting Initiative. Our performance against this indicator is provided in the chart below.
1 The content in this table has been subject to internal audit verification. See About This Report for more information.